Ignite Creation Date:
2024-07-17 @ 12:02 PM
Last Modification Date:
2025-12-16 @ 9:27 PM
Study NCT ID:
NCT06498518
Status:
None
Last Update Posted:
2025-07-11 00:00:00
First Post:
2024-07-02 00:00:00
Brief Title:
A Trial of Gemcitabine, Pembrolizumab and IMM-101 as First Line Treatment in Patients With Metastatic Pancreatic Cancer
Sponsor:
Karen Carty
Organization:
University of Glasgow
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neoplasms Pancreatic |
Keywords: